SCNI
Scinai Immunotherapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.86
−4.62%Leverage
- Debt / equity
- 0.31x
- Net debt / equity
- 0.06x
- Debt / assets
- 0.21x
- Debt / EBITDA
- -0.54x
- Net debt / EBITDA
- -0.11x
Liquidity & coverage
- Current ratio
- 1.56x
- Quick ratio
- 1.56x
- Cash ratio
- 1.28x
- Interest coverage
- -39.09x
- EBITDA / interest
- -30.90x
- Working capital
- $1.3M
Cash & dividend
- FCF / debt
- -2.10x
- Cash flow / debt
- -2.07x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026